Skip to main content
. 2021 Apr;24(4):444–450. doi: 10.22038/IJBMS.2021.46422.10720

Table 3.

Comparison of DPT expression (based on DPT expression category) between different groups of patients (real-time PCR data)

  DPT expression change  
  Under expression No change Overexpression P-value
Gender
Male 37.5% (9)* 37.5% (9)* 25.0% (6)* 0.49
Female 35.7% (5)* 21.4% (3)* 42.9% (6)*
Grade
Well differentiated 28.6% (4)* 28.6% (4)* 42.9 (6)* 0.61
Moderately differentiated 40.9% (9)* 31.8% (7)* 27.3% (6)*
Poorly differentiated 0% (0)* 100% (1)* 0% (0)*
Stage
I & II 38.5% (10)* 34.6% (9)* 26.9% (7)* 0.66
III & IV 27.3% (3)* 27.3% (3)* 45.5% (5)*
Lymph node involvement
N0 36% (9)* 36% (9)* 28% (7)* 0.75
N>0 33.3% (4)* 25% (3)* 4.7% (5)*
Tumor location
Proximal 50% (5)* 30% (3)* 20% (2)* 0.59
Distal 32% (9)* 32% (9)* 36% (10)*

*Number of samples

DPT: Dermatopontin